MedTrace Logo

Enhancing Attention in Adults With Compulsive Hoarding

NCT01100268 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2014-09-18

Study results available
· View outcomes & findings →

Summary

Available data suggest that compulsive hoarders have cognitive deficits, particularly with sustaining attention that might contribute their hoarding symptoms.

Conditions

  • Hoarding Disorder

Interventions

DRUG

Methylphenidate ER

Subjects will start at 18mg/day; the dose will be increased in increments of 18mg per week to reach 72mg/day.

Sponsors & Collaborators

  • Hartford Hospital

    collaborator OTHER

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Carolyn I. Rodriguez, M.D., Ph.D. · Columbia-NYSPI-RFMH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01100268 on ClinicalTrials.gov